Clinical Trials in Salt Lake City

Showing 3681-3700 of 16,694 trials

A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants

NCT06813924

The study aims to test if a new medicine called etavopivat potentially affects other medicines in healthy participants. The purpose of the study is to investigate whether the use of etavopivat affects the breakdown and metabolism of commonly used medicines in the body. During the study, participants will receive etavopivat and five different medicines that are already approved and available on the market, and which can be prescribed by doctors. These marketed medicines are called substrate drugs and they are: digoxin, pitavastatin, metformin, midazolam, and rosuvastatin. During a period of the study, participants will take 2 tablets of etavopivat daily for 10 consecutive days. The study will last for about 34 to 64 days.

Healthy Volunteers Sickle Cell Disease, Thalassemia

Novo Nordisk A/S37 participantsStarted Feb 2025

Salt Lake City, Utah, United States

COMPLETEDPhase 227 miles

ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder

NCT05749055

The ENCALM trial is designed to evaluate the efficacy and safety of ENX-102 in patients diagnosed with generalized anxiety disorder (GAD)

Generalized Anxiety Disorder

Engrail Therapeutics INC252 participantsStarted Jul 2023

Phoenix, Arizona, United States • Garden Grove, California, United States • Imperial, California, United States +29 more locations

A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants

ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder

Find Trials by Condition in Salt Lake City

Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer

Phase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis

A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis

Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC

Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors

Single-Sided Deafness and Asymmetric Hearing Loss

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

A Study to Evaluate ELX/TEZ/IVA on Cough and Physical Activity in Participants With Cystic Fibrosis (CF)

Comparing Hypothermic Temperatures During Hemiarch Surgery